Mpox and HIV: Understanding the Connection and Risks

Understanding the Link Between Mpox (Monkeypox) and HIV In recent times, concerns have arisen regarding the relationship between Mpox, formerly known as monkeypox, and Human Immunodeficiency Virus (HIV). While these are two distinct viral infections, understanding their potential connection is crucial for public health and individual well-being, especially within the Indian context. This article aims to clarify the relationship, discuss who is at higher risk, and outline preventive measures. What are Mpox and HIV? Mpox is a viral disease that shares similarities with smallpox. Its symptoms typically include swollen lymph nodes, a characteristic rash that can resemble lesions, and fever. The World Health Organization (WHO) renamed the virus from “monkeypox” to “mpox” in late 2022 to move away from stigmatizing and racist origins associated with the previous name. Transmission of mpox primarily occurs through close physical contact with an infected person’s rash, scabs, or bodily fluids. It can also spread through prolonged skin-to-skin contact, respiratory droplets during face-to-face interactions, and touching contaminated items. While sexual activity can be a mode of transmission due to close contact, it is important to note that mpox is not classified as a sexually transmitted infection (STI) or disease (STD). HIV is a virus that attacks the body’s immune system, specifically targeting CD4 cells (a type of white blood cell crucial for fighting off infections). If left untreated, HIV can severely weaken the immune system, making individuals highly susceptible to opportunistic infections. These are infections that typically do not cause illness in people with healthy immune systems but can be severe or life-threatening for those with compromised immunity. What Does the Research Say About Mpox and HIV? Recent data, including analyses from the Centers for Disease Control and Prevention (CDC) in the United States, have indicated a higher prevalence of mpox among individuals living with HIV. For instance, a significant portion of mpox diagnoses during a specific period were among people with a pre-existing HIV diagnosis. Researchers observed an increase in the weekly percentage of people living with HIV who concurrently developed mpox. It is vital to understand that neither virus causes the other . Mpox and HIV are caused by entirely different viral strains and are distinct conditions. However, there is an indirect connection: Increased Susceptibility: People living with untreated or advanced HIV, particularly those with low CD4 counts (generally below 350 cells/mm³), have a weakened immune system. This compromised immune status makes them more vulnerable to contracting mpox and potentially experiencing more severe illness or complications compared to individuals with healthy immune systems. Impact of Treatment: Conversely, individuals with well-controlled HIV, meaning their viral load is suppressed and their CD4 counts are healthy, are generally not at a significantly higher risk of severe mpox disease than HIV-negative individuals. Effective HIV treatment plays a crucial role in maintaining immune function and reducing susceptibility to other infections. Causes and Risk Factors for Mpox The primary mode of mpox transmission is through direct skin-to-skin contact with the mpox rash, scabs, or fluids from an infected person. This can occur through: Close physical contact, including hugging, kissing, and intimate contact. Prolonged face-to-face contact (breathing, talking, laughing). Sharing bedding or towels used by an infected person. While not exclusively an STI, sexual contact is a common way for the virus to spread due to the close physical proximity involved. Individuals who are immunocompromised, including many people living with HIV, are more susceptible to contracting mpox. Other risk factors include close contact with someone who has mpox or touching contaminated materials. Symptoms of Mpox The symptoms of mpox can vary but typically include: Fever Headache Muscle aches and backache Swollen lymph nodes (lymphadenopathy) Chills Exhaustion A rash that often begins on the face and then spreads to other parts of the body, including the genitals. The rash progresses through several stages, eventually forming scabs that fall off. Symptoms usually appear within 7 to 14 days after infection and can last for 2 to 4 weeks. Diagnosis of Mpox If you suspect you have mpox, it is essential to consult a healthcare professional. Diagnosis typically involves: Clinical Evaluation: A doctor will examine your symptoms, particularly the characteristic rash. Laboratory Testing: Samples from the rash lesions (scabs or fluid) are collected and sent to a laboratory for PCR testing to confirm the presence of the mpox virus. It is important to inform your doctor about any recent exposures or potential risk factors, including your HIV status. Treatment for Mpox For most individuals, mpox is a self-limiting illness, meaning it resolves on its own without specific treatment. Supportive care is key, focusing on managing symptoms such as pain and fever with over-the-counter medications. Ensuring adequate hydration and rest is also important. In cases of severe illness or for individuals at high risk of complications (such as those with weakened immune systems), antiviral medications may be considered. These are typically reserved for more severe presentations. Prevention Strategies Preventing mpox infection is paramount, especially for vulnerable populations. Key preventive measures include: Vaccination: The mpox vaccine is highly effective in preventing infection and reducing the severity of illness. It is typically administered as a two-dose series, with the second dose given about 4 weeks after the first. Getting both doses is crucial for optimal protection. Avoiding Close Contact: Limit close, skin-to-skin contact with individuals who have an mpox rash or are diagnosed with the virus. Good Hygiene Practices: Frequent handwashing with soap and water or

In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.